Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 85,807 | 60,949 | N/A | N/A |
| Marketable Securities | 16,966 | N/A | N/A | N/A |
| Receivables | 7,385 | 500 | N/A | N/A |
| TOTAL | $111,900 | $61,733 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 4,079 | 4,260 | N/A | N/A |
| Other Non-Current Assets | 3,085 | 536 | 0 | 0 |
| TOTAL | $7,164 | $4,796 | $N/A | $N/A |
| Total Assets | $119,064 | $66,529 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,250 | 2,576 | 0 | 0 |
| Accrued Expenses | 6,922 | 2,508 | N/A | N/A |
| TOTAL | $8,172 | $5,084 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 912 | 811 | 0 | 0 |
| TOTAL | $912 | $811 | $N/A | $N/A |
| Total Liabilities | $9,084 | $5,895 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | 1 | N/A | N/A |
| Retained earnings | -76,295 | -71,470 | N/A | N/A |
| Other shareholders' equity | 186,274 | 132,103 | 0 | 0 |
| TOTAL | $109,980 | $60,634 | $N/A | $N/A |
| Total Liabilities And Equity | $119,064 | $66,529 | $0 | $0 |